Indiabulls Pharmaceuticals, cipla pharmaceuticals.#Cipla #pharmaceuticals

Posted On Feb 8 2018 by

To be a patient and physician centric, innovative, best-in-class pharmaceutical company Patient centric Excellence in product quality Emerging and unavailable medical needs Patient assistance and affordability Availability at local pharmacies Physician centric Provide for 80%+ of physician’s prescribing needs Seamless integration with physician’s office and associated pharmacies Provide best-in-class service to physician and associated pharmacies Innovation Innovation in product research and formulation development Open science model to drive differentiation Innovative service solutions for patients and physicians Best-in-Class Be a top 3 domestic pharmaceutical company in each therapeutic area over time Attract, develop, excite and retain exceptional talent Overview Indiabulls Pharmaceuticals …


Cipla, cipla.#Cipla

Posted On Jan 14 2018 by

Careers Careers: Cipla employs handpicked professionals not just for their knowledge and experience but for their zeal to make a difference to the world of healthcare. The company believes that our biggest assets are the employees, who lead us to prosperity and growth in the future. Driven by the vision, “None shall be denied”, Cipla’s focus has always been on making affordable, world-class medicines with a reputation for uncompromising quality standards across the world. Working at Cipla: Cipla does not just give you a job, it takes pride in helping you build a career for yourself by giving you opportunities …


Cipla, Aurobindo Pharma acquire products divested by Teva in US #pharmaceutical #manufacturers #association

Posted On Jan 8 2018 by

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …


Cipla, Aurobindo Pharma acquire products divested by Teva in US #noel #pharma

Posted On Nov 30 2017 by

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …


Cipla, Aurobindo Pharma acquire products divested by Teva in US #online #pharma

Posted On Aug 15 2017 by

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …


Cipla, Aurobindo Pharma acquire products divested by Teva in US #new #pharmaceutical #companies

Posted On Jul 9 2017 by

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …


Cipla, Aurobindo Pharma acquire products divested by Teva in US #sciele #pharma

Posted On Feb 12 2017 by

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …


Cipla, Aurobindo Pharma acquire products divested by Teva in US #pharma #manufacturing

Posted On Jan 30 2017 by

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …


Cipla, Aurobindo Pharma acquire products divested by Teva in US #top #pharma #companies #2013

Posted On Dec 9 2016 by

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …


Cipla, Aurobindo Pharma acquire products divested by Teva in US #purdue #pharmaceutical

Posted On Nov 21 2016 by

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …